What Is CJC-1295 (No Dac)? A Research Guide

What is CJC-1295 (No Dac)?

CJC-1295 (No Dac) is supplied strictly for laboratory and research use only, and nothing in this guide describes use in humans or animals. It is a synthetic research peptide that scientists reference within the growth hormone releasing hormone family, and it is most useful to understand first as a molecule rather than as anything applied outside a controlled research setting.

At a structural level, CJC-1295 (No Dac) is an analogue of growth hormone releasing hormone, often abbreviated to GHRH. It is built on the first twenty-nine amino acids of the natural GHRH sequence, the fragment most commonly studied in the literature as GRF(1-29). To that base, the CJC-1295 design introduces a small set of amino acid substitutions that are intended to make the peptide more stable and slower to degrade under laboratory conditions than the unmodified fragment. In the research community this modified fragment is also referred to by names such as Modified GRF(1-29).

The distinguishing feature is signalled by the phrase No Dac. Dac is short for Drug Affinity Complex, a separate design element that, when present, is intended to bind the peptide to carrier proteins so that it degrades more slowly in laboratory assays. The No Dac version deliberately omits that complex. Removing it is the entire point of the variant, and it is what separates CJC-1295 (No Dac) from its longer lasting counterpart at a molecular level.

View CJC-1295 (No Dac)

The structure at a glance

Because the naming around this peptide can be confusing, it helps to separate the fixed structural facts from the marketing language that sometimes surrounds it. The points below describe what the molecule is, not what it does.

• Class: a synthetic analogue of growth hormone releasing hormone (GHRH).
• Base sequence: derived from the first twenty-nine amino acids of GHRH, the GRF(1-29) fragment.
• Modifications: a small set of amino acid substitutions intended to improve stability against enzymatic breakdown in the laboratory.
• No Dac: the Drug Affinity Complex is deliberately absent, which is what defines this variant and gives it a shorter laboratory persistence than the DAC bearing form.
• Common research synonyms: Modified GRF(1-29) and related GRF(1-29) analogue names.

Why researchers study it

Interest in CJC-1295 (No Dac) among researchers stems from its relationship to the growth hormone axis, one of the most studied signalling systems in endocrinology. GHRH is characterised as the hormone that acts on the pituitary gland in the release of growth hormone, and analogues of GHRH are valuable to laboratories precisely because they let scientists probe how that pathway responds to a defined, stable input in experimental models.

As a GHRH analogue, CJC-1295 (No Dac) is investigated in preclinical and laboratory research for its role in growth hormone releasing pathways and pituitary signalling models. Researchers are interested in questions such as how a modified GRF(1-29) sequence binds to the GHRH receptor, how substitutions to the base fragment change stability in vitro, and how the presence or absence of the Drug Affinity Complex alters the profile of the molecule in laboratory assays.

The No Dac variant in particular attracts attention because its shorter laboratory persistence is associated with a more transient, pulse like signal in experimental systems. That characteristic makes it a useful comparator in studies designed to distinguish short acting from long acting GHRH analogues at a mechanistic level. None of this research interest describes an outcome in a person or animal. It is entirely mechanistic curiosity about how the peptide behaves in controlled laboratory work.

The growth hormone releasing pathway in research models

To understand why a GHRH analogue is studied at all, it helps to sketch the pathway it is associated with, again strictly in a research framing. In the literature the pituitary is described as secreting growth hormone in a naturally pulsatile pattern, and that pulse is shaped by a balance of releasing and inhibiting signals. GHRH is characterised as the primary releasing signal, while somatostatin is characterised as the brake.

Analogues such as CJC-1295 (No Dac) are of research interest because they let investigators supply a defined GHRH like stimulus and then observe the downstream events in cell or tissue models, including receptor engagement, intracellular signalling, and the way the system returns to baseline. Because the No Dac form does not carry the Drug Affinity Complex, it is often chosen for models where a shorter, cleaner signal is preferable to a prolonged one.

It is also common to see CJC-1295 (No Dac) discussed alongside growth hormone secretagogues, a separate class of research peptides that are studied through a different receptor. Researchers examine the two classes together to understand how distinct signalling routes into the same axis compare in laboratory systems. This comparative work is the kind of mechanistic question the peptide is characterised for, and it remains confined to preclinical and laboratory settings.

How to verify quality

For any research peptide, the single most important practical question is not what the label claims but whether the contents of the vial genuinely match it. A compound like CJC-1295 (No Dac), with several closely related analogues in circulation and easily confused naming, is exactly the sort of material where independent verification matters. At Pepology, every batch is third-party lab tested by Novagen Laboratories, and each batch is accompanied by a certificate of analysis that the customer can verify.

A certificate of analysis is the document that records the laboratory work performed on a batch. Rather than quoting any specific figures here, it is more useful to understand the types of analysis such a certificate typically reports. Identity confirmation establishes that the molecule present is the peptide named, commonly through techniques such as mass spectrometry that check the molecular weight against the expected sequence. Purity analysis, usually carried out by high performance liquid chromatography (HPLC), characterises how much of the sample is the target peptide compared with related impurities.

The verification step that buyers most often overlook is the simplest one, which is matching the lot or batch number printed on the vial to the lot number on the certificate. A certificate only tells you something meaningful if it belongs to the vial in your hand, so this cross-check is not a formality. Where a public register is offered, you can also confirm the certificate independently rather than relying solely on a document forwarded by the seller.

• Confirm a certificate of analysis exists for the specific batch you received.
• Match the lot or batch number on the vial to the lot number on the certificate.
• Check that identity has been confirmed and that a purity method such as HPLC is reported.
• Verify the certificate independently on a public register rather than trusting a forwarded copy alone.

Verify a batch certificate

Sourcing CJC-1295 (No Dac) in Australia

When sourcing a research peptide in Australia, buying from a supplier that is transparent about where the material comes from and how it is tested is worth far more than any claim on a product page. Pepology is an Australian, Gold Coast owned and operated retailer of research peptides, and CJC-1295 (No Dac) is supplied for laboratory and research use only.

The advantage of buying locally with clear documentation is that verification stops being an act of faith. Because every batch is third-party lab tested by Novagen Laboratories with a certificate of analysis you can check for yourself, the identity and purity of the material are questions you can answer rather than assume. For a compound with as many similarly named variants as CJC-1295, that traceability is the practical difference between a batch you can characterise and one you cannot.

If you are evaluating CJC-1295 (No Dac) for a research setting, review the product listing and its accompanying documentation, and use the verification tools to confirm the batch before it enters any work. It remains a material for laboratory and research use only, and it is not for human or animal use.

View CJC-1295 (No Dac) Browse all research peptides